Article

TV, print promo launched for dry eye therapy

Irvine, CA-Allergan has launched the first direct-to-consumer (DTC) advertising campaign for its chronic dry eye therapy, cyclosporine ophthalmic emulsion 0.05% (Restasis). The television spots and print advertising feature actress Janine Turner (Maggie O'Connell on the television series Northern Exposure), who is a chronic dry eye sufferer who takes cyclosporine.

Irvine, CA-Allergan has launched the first direct-to-consumer (DTC) advertising campaign for its chronic dry eye therapy, cyclosporine ophthalmic emulsion 0.05% (Restasis). The television spots and print advertising feature actress Janine Turner (Maggie O'Connell on the television series Northern Exposure), who is a chronic dry eye sufferer who takes cyclosporine.

"Chronic dry eye is one of the most common complaints heard by eye-care professionals, yet many people don't recognize they could have the disease or understand its severity," said Erik Hafkey, Restasis brand manager.

"The DTC campaign gives us the opportunity to raise awareness of chronic dry eye and tell consumers about the availability of the only prescription therapy for chronic dry eye and the exceptional safety and efficacy profile of Restasis," he added.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.